切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 140 -145. doi: 10.3877/cma.j.issn.1674-3903.2023.03.003

论著

新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究
刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正()   
  1. 510260 广州医科大学附属第二医院器官移植科
  • 收稿日期:2023-01-31 出版日期:2023-06-25
  • 通信作者: 陈正
  • 基金资助:
    广州医科大学临床重点专科项目基金(010004001); 广州市基础与应用基础研究项目(202102020417); 广东省医学科研基金项目(A2021384); 广州市泌尿疾病学重点学科建设项目(2021-2023)

Drug compliance of immunosuppressant in kidney transplant recipients during the COVID-19 pandemic

Luhao Liu, Yongxin Su, Lijuan Zeng, Peng Zhang, Rongxin Chen, Lu Xu, Guanghui Li, Jiali Fang, Junjie Ma, Zheng Chen()   

  1. Department of organ transplantation, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China
  • Received:2023-01-31 Published:2023-06-25
  • Corresponding author: Zheng Chen
引用本文:

刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正. 新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究[J/OL]. 中华移植杂志(电子版), 2023, 17(03): 140-145.

Luhao Liu, Yongxin Su, Lijuan Zeng, Peng Zhang, Rongxin Chen, Lu Xu, Guanghui Li, Jiali Fang, Junjie Ma, Zheng Chen. Drug compliance of immunosuppressant in kidney transplant recipients during the COVID-19 pandemic[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(03): 140-145.

目的

对新型冠状病毒感染(COVID-19)疫情期间肾移植受者服药依从性现状进行调查,并分析其影响因素。

方法

采用方便抽样法选取2021年6月至12月在广州医科大学附属第二医院器官移植科门诊随访中心进行随访的540例肾移植受者作为研究对象。采用一般资料调查表、对COVID-19和新冠疫苗认识程度的调查问卷和免疫抑制剂服药依从性调查问卷进行问卷调查。全部问卷回收后及时进行整理分析,剔除无效问卷。根据免疫抑制剂服药依从性情况将受者分为依从性高组和依从性低组。组间正态分布计量资料采用成组t检验进行比较,计数资料采用χ2检验进行比较。P<0.05为差异有统计学意义。

结果

本研究共发放调查问卷540份,剔除无效问卷29份,回收有效问卷511份,回收有效率94.6%(511/540)。511例受者中403例(78.9%)表示对COVID-19疫情存在担心,但450例(88.1%)受者表示自己不会发生COVID-19,目前有5例(1.0%)受者发生过COVID-19。260例(50.9%)受者表示愿意接种新冠疫苗,486例(95.1%)会选择接种灭活疫苗;414例(81.0%)受者最担心出现排斥反应。511例受者过去1个月内,忘记服用抗排斥反应药物1次及以上受者203例(39.7%);连续2次或多次忘记服用抗排斥反应药物的受者16例(3.1%);提前或延迟2 h服药的受者213例(41.7%);自行调整抗排斥反应药物剂量的受者12例(2.3%)。225例(44.0%)受者主要因个人因素导致漏服或自行停用抗排斥反应药物,87例(17.0%)表示因工作繁忙而导致错误服药,因疫情导致无法出门购药只有8例(1.6%)。511例受者中247例受者纳入依从性高组,余264例受者纳入依从性低组。两组受者教育状况及最近1次复查血清肌酐水平差异有统计学意义(χ2=117.12,t=-6.48,P均<0.05)。

结论

肾移植受者术后服药依从性仍有待提高,其服药依从性可能与文化程度有关,应采取相应的干预措施提高受者服药依从性。

Objective

To investigate the current status of drug compliance of immunosuppressant and analyze its influencing factors in kidney transplant recipients during the COVID-19 pandemic.

Methods

540 renal transplant recipients who were followed up in the outpatient clinic in the Organ Transplantation Center of the Second Affiliated Hospital of Guangzhou Medical University, from June 2021 to December 2021, were selected by the convenience sampling method to do the questionnaire. Surveys on general information, COVID-19 and COVID-19 vaccine, and drug compliance of immunosuppressant were conducted in renal transplant recipients. All the questionnaires were promptly organized and analyzed after collection, and then the invalid questionnaires were excluded. The recipients were divided into high drug compliance group and low drug compliance group according to drug compliance of immunoswppressant. The measurement data of normal distribution between groups were compared by group t test. Chi-squared test was used to compare the counting data. P<0.05 indicates a statistically significant difference.

Results

A total of 540 survey questionnaires were distributed in this study, with 29 invalid questionnaires excluded. A total of 511 valid questionnaires were collected, with a recovery effectiveness rate of 94.6% (511/540). Among 511 recipients, 403 recipients (78.9%) expressed concern about the COVID-19 pandemic, but 450 recipients (88.1%) stated that they would not experience COVID-19. Only 5 (1.0%) recipients had experienced COVID-19. 260 (50.9%) recipients were willing to receive COVID-19 vaccine, and 486 recipients (95.1%) would choose to receive inactivated vaccine, 414 recipients (81.0%) were most concerned about acute rejection for vaccination. For 511 recipients in the past month, 203 recipients (39.7%) forgot to take immunosuppressive medication once or more; 16 recipients (3.1%) forgot to take immunosuppressive medication twice or multiple times; 213 recipients (41.7%) received immunosuppressive medication early or delayed for 2 hours; 12 recipients (2.3%) adjusted the dosage of immunosuppressive medication on their own. 225 recipients (44.0%) forgot or stopped taking the anti-rejection drugs due to personal factors. 87 recipients (17.0%) reported taking medication incorrectly due to busy work schedules. Only 8 recipients (1.6%) were unable to go out to purchase medication due to the COVID-19 pandemic. Among 511 recipients, 247 recipients were included in high drug compliance group and 264 recipients were included in low drug compliance group. There were significant differences between the two groups in terms of educational level and serum creatinine level for recent time (χ2=117.12, t=-6.48, all P<0.05).

Conclusions

The drug compliance of kidney transplant recipients remains to be improved, and the education status may be related to the drug compliance of immunosuppressant of kidney transplant recipients. Corresponding intervention measures should be taken to improve the drug compliance.

表1 纳入调查的511例肾移植受者一般资料
表2 纳入调查的511例肾移植受者对COVID-19和新冠疫苗认识程度的调查结果
表3 纳入调查的511例肾移植受者免疫抑制剂服药依从性BAASIS量表各条目水平[例(%)]
表4 免疫抑制剂服药依从性高和依从性低组肾移植受者一般资料比较
1
Li CJ, Li L. Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use[J]. Drug Des Devel Ther, 20159:473-485.
2
Manickavasagar R, Wong G, Alexander SI, et al. Allograft outcome following repeat transplantation of patients with non-adherence-related first kidney allograft failure: a population cohort study[J]. Transpl Int, 201932(12):1247-1258.
3
Wang Y, Veltkamp D, van der Boog P, et al. Illness perceptions and medication nonadherence to immunosuppressants after successful kidney transplantation: a cross-sectional study[J]. Transpl Int, 202235:10073.
4
Zhang P, Zhu X, Yan J, et al. Identification of immunosuppressive medication nonadherence factors through a combined theory model in renal transplant recipients: 6-12[J]. Front Pharmacol, 202112:655836.
5
Kobayashi S, Tsutsui J, Okabe S, et al. Medication nonadherence after kidney transplantation: an internet-based survey in Japan[J]. Psychol Health Med, 202025(1):91-101.
6
贾丽燕,景懿磊,张千,等. 新型冠状病毒肺炎暴发期间肝移植受者服药依从性与生命质量调查研究[J]. 肝脏202126(6):655-660.
7
Cheung CY, Chan KM, Tang G, et al. Immunosuppressive medication adherence in kidney transplant recipients during the COVID-19 pandemic: a cross-sectional study in Hong Kong[J]. Transplant Proc, 202153(8):2447-2450.
8
王振迪,夏秋翔,曾宪鹏,等. 公众对异种移植态度的问卷调查分析[J]. 中华器官移植杂志202243(9):536-543.
9
沈如芬,沈鸣雁,曾静,等. 居家肾移植受者新型冠状病毒肺炎知信行调查及影响因素分析[J/CD]. 中华移植杂志:电子版202014(6):373-377.
10
Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review[J]. Transplantation, 201090(2):205-219.
11
Nerini E, Bruno F, Citterio F, et al. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?[J]. J Nephrol, 201629(5):627-636.
12
Demian MN, Shapiro RJ, Thornton WL. An observational study of health literacy and medication adherence in adult kidney transplant recipients[J]. Clin Kidney J, 20169(6):858-865.
13
De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss transplant cohort study[J]. Transpl Int, 201427(7):657-666.
14
林俊,丁小明,朱一辰,等. 肾移植受者新型冠状病毒疫苗接种建议[J]. 中华器官移植杂志202243(2):67-73.
15
中华医学会器官移植学分会. 新型冠状病毒肺炎疫情期间全国器官捐献与移植工作的指导原则(二○二○年二月二十三日通过)[J]. 器官移植202011(2):179-184.
16
Prihodova L, Nagyova I, Rosenberger J, et al. Social participation after kidney transplantation as a predictor of graft loss and mortality over 10 years: a longitudinal study[J]. Transplantation, 201599(3):568-575.
17
Weng LC, Yang YC, Huang HL, et al. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study[J]. J Adv Nurs, 201773(1):228-239.
18
Huuskes BM, Scholes-Robertson N, Guha C, et al. Kidney transplant recipient perspectives on telehealth during the COVID-19 pandemic[J]. Transpl Int, 202134(8):1517-1529.
19
Duivenvoorden R, Vart P, Noordzij M, et al. Clinical, functional, and mental health outcomes in kidney transplant recipients 3 months after a diagnosis of COVID-19[J]. Transplantation, 2022106(5):1012-1023.
[1] 钱雅君, 虞竹溪, 徐颖, 董丹江, 顾勤. 危重型新型冠状病毒感染合并侵袭性肺曲霉病的临床特征和高危因素分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(01): 3-9.
[2] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[3] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[4] 吕玥彤, 靳梦圆, 周大为, 叶啟发. 机器人辅助下肾移植的临床进展与争议[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 242-246.
[5] 尚丽红, 王志华, 张文艳, 朱琳茹, 周华. 内皮粘蛋白抗体与肾移植术后抗体介导排斥反应和移植肾预后的研究[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 165-170.
[6] 吕军好, 林锦雯, 张心怡, 陈江华. 细胞外囊泡在肾移植诊断和治疗中的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 186-192.
[7] 陆婷, 陈浩, 王雪静, 谭若芸, 彭宇竹. 肾移植术后一年发生代谢综合征的危险因素分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 98-103.
[8] 郭明星, 徐烨, 徐菀佚, 赵莹, 刘冉佳, 潘晨, 崔向丽. 2017—2022年中国105家医院肾移植术后门诊受者免疫抑制剂用药分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 104-109.
[9] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[10] 田学, 谢晖, 王瑞兰. 急性呼吸窘迫综合征相关肺纤维化的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 258-264.
[11] 王晶晶, 谢晖, 邓璞钰, 张晨晨, 田学, 谢云, 王瑞兰. 新型冠状病毒感染ARDS患者EIT监测下俯卧位通气成像的改变[J/OL]. 中华重症医学电子杂志, 2024, 10(01): 31-37.
[12] 李浩南, 张煜彭, 付焱, 冯继伟, 刘凯, 张文凯. 缝隙连接蛋白43在肺部疾病中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(01): 60-65.
[13] 张秋玥, 程羽, 牛雨田, 唐茂芝, 张克勤, 张懿, 郭亚楠, 涂增. 肾移植与人体微生态的相关性研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 207-213.
[14] 叶禾清, 李杰, 张玉元, 胡炉淇, 吴白露, 李鑫, 叶书文, 李一帆, 高玥, 詹鹏超, 吕培杰, 李臻. 载药微球化疗栓塞联合多纳非尼及PD-1治疗中晚期大肝癌的疗效分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 212-216.
[15] 张宇, 王林. 急诊内科老年新型冠状病毒感染患者低钠血症发生情况调查分析[J/OL]. 中华老年病研究电子杂志, 2024, 11(02): 10-14.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?